Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression
Version of Record online: 7 MAY 2014
© 2014 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Volume 165, Issue 4, pages 357–364, June 2014
How to Cite
2014. Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression. Am J Med Genet Part B 165B:357–364., , , , , , , , , , , .
- Issue online: 1 JUN 2014
- Version of Record online: 7 MAY 2014
- Manuscript Accepted: 14 APR 2014
- Manuscript Received: 4 NOV 2013
- Scientific Research. Grant Number: 24390160
- Scientific Research on Innovative Areas (Research in a Proposed Research Area). Grant Number: 21119002
- K6 score;
- HumanMethylation 450K Microarray
Brain-derived neurotrophic factor (BDNF) is involved in the survival, development, and synaptic plasticity of neurons. BDNF is believed to be associated with the pathophysiology of psychiatric disorders. Several studies have suggested the relevance of DNA methylation in its promoter region with depression. Here, we report different methylation statuses in groups with different depressive scores or undergoing different levels of job-stress. DNA samples were extracted from the saliva of 774 Japanese workers, and the methylation status was determined using the Illumina HumanMethylation 450 K Microarray. Depressive symptoms were measured using the Kessler's K6 questionnaire. Job-stress scales were assessed via a self-administered questionnaire. Independent DNA pools were formed based on K6 and job-strain scores, and the methylation levels were compared among these pools. The average DNA methylation rate was significantly decreased in the highest K6 score group compared to the lowest group (methylated signals, 14.2% vs. 16.5%, P = 2 · 16 × 10−198). This difference remained for the CpG island in the promoter region (10.4% vs. 5.8%, P = 3 · 67 × 10−133). Regarding the job-strain score, there was a slight increase in the methylation level of the whole gene in the group with the highest score compared to that with the lowest score; however, these groups showed no difference in the promoter region. Our results revealed significant changes in the DNA methylation status of the complete human BDNF gene in persons with depression compared to normal individuals, especially in the promoter region of exon 1. This indicates that DNA methylation in this gene is a promising biomarker for diagnosing depression. © 2014 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.